國際生醫工程博士學位學程

Medicine and Dentistry

1. Platelet 100%
2. Platelet Lysate 90%
3. In Vitro 66%
4. Malignant Neoplasm 42%
5. Thrombocyte Concentrate 39%
6. Medicine 36%
7. Growth Factor 35%
8. Apoplexy 34%
9. Nanoparticle 34%
10. Restylane 33%
11. Implant 32%
12. Cell Therapy 31%
13. Cancer Cell 31%
14. Injury 29%
15. Systematic Review 28%
16. Mesenchymal Stem Cell 27%
17. Wound Healing 26%
18. Gelatin 23%
19. Disease 23%
20. Meta-Analysis 23%
21. Circulating Tumor Cell 23%
22. Neoplasm 23%
23. Randomized Controlled Trial 22%
24. Traumatic Brain Injury 22%
25. COVID-19 22%
26. Blood Transfusion 21%
27. Combination Therapy 21%
28. Osseointegration 21%
29. Reactive Oxygen Species 20%
30. Dry Eye 20%
31. Bone Regeneration 19%
32. Electrostimulation 19%
33. Oxidative Stress 18%
34. Knee 18%
35. Biocompatible Material 18%
36. Neuroprotective Agent 18%
37. Urination 17%
38. Magnetic Resonance Imaging 17%
39. Platelet-Rich Fibrin 17%
40. Dental Pulp Stem Cell 17%
41. Ex Vivo 16%
42. Osteolysis 16%
43. Isotopes of Calcium 16%
44. Angiogenesis 16%
45. Pathogen 16%
46. Spasticity 15%
47. Obstructive Sleep Apnea 15%
48. Dental Implant 15%
49. Endothelial Cell 15%
50. Parkinson's Disease 14%
51. Electrical Brain Stimulation 14%
52. Biological Marker 14%
53. Biological Therapy 14%
54. Blood Product 14%
55. Cell Viability 14%
56. Low and Middle Income Countries 14%
57. Oral Implants 14%
58. Signal Transduction 14%
59. X-Ray Microtomography 13%
60. Ossification 13%
61. Neuromodulation 13%
62. Xenograft 13%
63. Pulse Rate 13%
64. Fetal Bovine Serum 13%
65. Osteoarthritis 13%
66. Biocompatibility 13%
67. Human Dental Pulp Stem Cell 13%
68. Breast Cancer 12%
69. Clinical Trial 12%
70. Fibroblast 12%
71. Spinal Cord Injury 12%
72. Epidermal Growth Factor Receptor 12%
73. Neurologic Disease 12%
74. Cell Proliferation 12%
75. Personalized Medicine 12%
76. Knee Osteoarthritis 12%
77. Vasculotropin 12%
78. microRNA 12%
79. Alginic Acid 11%
80. Bladder 11%
81. Oocyte 11%
82. Serum Total Protein 11%
83. Corneal Neovascularization 11%
84. Heart Rate Variability 11%
85. Mandibular First Molar 11%
86. Cytokine 11%
87. Antioxidant 11%
88. In Vitro Fertilisation 11%
89. Hypoxia 11%
90. Anticarcinogen 11%
91. Polyethyleneimine 11%
92. Lung Cancer 11%
93. Cytotoxicity 10%
94. Metastatic Carcinoma 10%
95. Bladder Function 10%
96. Infection 10%
97. Polypyrrole 10%
98. Polypyrrole 10%
99. Cancer Therapy 10%
100. Bleeding 10%

Pharmacology, Toxicology and Pharmaceutical Science

1. Nanoparticle 87%
2. Malignant Neoplasm 75%
3. Neoplasm 67%
4. Disease 43%
5. Inflammation 42%
6. Chitosan 42%
7. Mesoporous Silica Nanoparticle 41%
8. Gelatin 38%
9. Combination Therapy 36%
10. Nanocarrier 35%
11. Hyaluronic Acid 35%
12. Polypyrrole 33%
13. Wound Healing 27%
14. Antiinfective Agent 26%
15. Growth Factor 26%
16. Nanomaterial 24%
17. Drug Delivery System 24%
18. Fucoidan 24%
19. Dry Eye 24%
20. Mouse 23%
21. Injury 22%
22. Reactive Oxygen Metabolite 22%
23. Lung Cancer 20%
24. Thrombocyte Concentrate 20%
25. Chemotherapy 19%
26. Sleep Disordered Breathing 18%
27. Doxorubicin 18%
28. Biocompatibility 18%
29. Liposome 18%
30. Diabetes Mellitus 17%
31. Parkinson's Disease 17%
32. Infection 17%
33. Cell Viability 16%
34. Tumor Microenvironment 16%
35. Wound 16%
36. Plasma Protein 15%
37. Glioblastoma 15%
38. Traumatic Brain Injury 15%
39. Mouse Model 15%
40. Nanomedicine 15%
41. Hemodialysis 15%
42. Therapeutic Effect 15%
43. Rat Model 15%
44. Hyperthermia 15%
45. Epigallocatechin Gallate 15%
46. Neuroprotective Agent 15%
47. Breast Cancer 14%
48. Eye Disease 14%
49. Platelet-Rich Fibrin 14%
50. Rheumatoid Arthritis 14%
51. Infectious Agent 14%
52. Polyethyleneimine 14%
53. Curcumin 14%
54. Alginic Acid 13%
55. Polysaccharide 13%
56. Thrombus 13%
57. Leporidae 13%
58. Cohort Study 13%
59. Immunoglobulin G 13%
60. Blood Clotting Factor 13%
61. Bioavailability 12%
62. Fibrinogen 12%
63. Biomaterial 12%
64. Anti-Inflammatory Drug 12%
65. Docetaxel 12%
66. Microparticle 12%
67. Cytotoxicity 11%
68. Symptom 11%
69. Antioxidant 11%
70. Cornea Neovascularization 11%
71. SARS Coronavirus 11%
72. Ferroptosis 11%
73. Iron Oxide 11%
74. Western Blot 11%
75. Poloxamer 11%
76. Drug Resistance 11%
77. Kaempferol 10%
78. Biodistribution 10%
79. Hepatitis C Virus 10%
80. Fibrinolytic Agent 10%
81. Brain Tumor 10%
82. Epidermal Growth Factor Receptor 10%
83. Clinical Trial 10%
84. Rabbit Model 10%
85. Micelle 10%
86. Side Effect 10%
87. Macrogol 9%
88. Cytokine 9%
89. Photothermal Therapy 9%
90. P-Selectin 9%
91. Anticarcinogen 9%
92. Sleep Disorder 9%
93. Drug Release 9%
94. Colon Cancer 9%
95. Chronic Kidney Failure 9%
96. Polyethylene Glycol 9%
97. Thrombin 9%
98. Thrombosis 9%
99. Buffer 9%
100. Surface Plasmon Resonance 9%